Benjamin L. Schlechter

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial”.

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Blood Advances(2020)10.1182/bloodadvances.2020001804

N/A

0.920DataRank · unranked

30 citations

Joanna Roopkumar, Mäneka Puligandla, Benjamin L. Schlechter, Anish V. Sharda, David M. Peereboom +6 more

Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3930

N/A

0.581DataRank · unranked

47 citations

Rachel B. Keller, Kevin S. Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan +27 more

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2005

N/A

0.503DataRank · unranked

14 citations

Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose Kochupurakkal +23 more

Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4116

N/A

0DataRank · unranked

117 citations

Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea, Raul S. González +20 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073

N/A

0DataRank · unranked

28 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436

N/A

0DataRank · unranked

13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1027

N/A

0DataRank · unranked

6 citations

Osama E. Rahma, Kevin Tyan, Yvonne Li, Anita Giobbie‐Hurder, Benjamin L. Schlechter +18 more